Clinical Trial Update: Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)

View source ↗

Summary

An expanded access update for an individual patient with uterine sarcoma to receive everolimus; the program is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Sarcoma

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Uterine Sarcoma | Status: NO_LONGER_AVAILABLE